CD44-targeted Hyaluronic Acid-Curcumin Prodrug Protects Renal Tubular Epithelial Cell Survival from Oxidative Stress Damage.

Jing-Bo Hu,Shu-Juan Li,Xu-Qi Kang,Jing Qi,Jia-Hui Wu,Xiao-Juan Wang,Xiao-Ling Xu,Ying,Sai-Ping Jiang,Jian You,Yong-Zhong Du
DOI: https://doi.org/10.1016/j.carbpol.2018.04.011
IF: 10.723
2018-01-01
Carbohydrate Polymers
Abstract:Based on the abnormally increased expression of CD44 receptors on renal tubule epithelial cells during ischemia/reperfusion-induced acute kidney injury (AKI), we developed a hyaluronic acid-curcumin (HA-CUR) polymeric prodrug targeting to epithelial cells and then relieving oxidative stress damages. The water solubility of HA-CUR was significantly enhanced and approximately 27-fold higher than that of CUR. Cellular uptake test showed HA-CUR was preferably internalized by H2O2-pretreated tubular epithelial (HK-2) cells compared with free CUR benefiting from the specific binding between HA and CD44 receptors. Biodistribution results further demonstrated the increased accumulation of HA-CUR in kidneys with 13.9-fold higher than that of free CUR. Pharmacodynamic studies indicated HA-CUR effectively ameliorated AKI, and the exact mechanism was that HA-CUR protected renal tubule epithelial cells from oxidative stress damage via inhibiting PtdIns3K-AKT-mTOR signaling pathway. Taken together, this study provides a new therapeutic strategy for the treatment of AKI based on the pathogenesis of the disease.
What problem does this paper attempt to address?